{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:48:16Z","timestamp":1759495696453,"version":"3.40.5"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.yrtph.2017.01.010","type":"journal-article","created":{"date-parts":[[2017,1,31]],"date-time":"2017-01-31T04:01:05Z","timestamp":1485835265000},"page":"25-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Assessment of skin sensitization under REACH: A case report on vehicle choice in the LLNA and its crucial role preventing false positive results"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0622-852X","authenticated-orcid":false,"given":"Nico","family":"Watzek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne Noreen","family":"Kolle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bennard","family":"van Ravenzwaay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.yrtph.2017.01.010_bib1","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.yrtph.2015.10.005","article-title":"Alternatives for skin sensitisation: hazard identification and potency categorisation: report from an EPAA\/CEFIC LRI\/Cosmetics Europe cross sector workshop, ECHA Helsinki, April 23rd and 24th 2015","volume":"73","author":"Basketter","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2017.01.010_bib2","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1039\/c2cc36589h","article-title":"Acid-degradable polymers for drug delivery: a decade of innovation","volume":"49","author":"Binauld","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.yrtph.2017.01.010_bib3","series-title":"Roadmap for SVHC Identification and Implementation of REACH Risk Management Measures","isbn-type":"print","author":"ECHA","year":"2015","ISBN":"https:\/\/id.crossref.org\/isbn\/9789292472924"},{"issue":"20","key":"10.1016\/j.yrtph.2017.01.010_bib4","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1021\/bi900413g","article-title":"Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases","volume":"48","author":"Edmondson","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.yrtph.2017.01.010_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.tox.2004.12.038","article-title":"An European inter-laboratory validation of alternative endpoints of the murine local lymph node assay 2nd round","volume":"212","author":"Ehling","year":"2005","journal-title":"Toxicology"},{"issue":"L 396","key":"10.1016\/j.yrtph.2017.01.010_bib6","first-page":"1","volume":"49","author":"EU","year":"2006","journal-title":"Official J. Eur. Union"},{"key":"10.1016\/j.yrtph.2017.01.010_bib7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.yrtph.2008.08.018","article-title":"Local lymph node assay (LLNA): comparison of different protocols by testing skin sensitizing epoxy resin components","volume":"52","author":"Gamer","year":"2008","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"2","key":"10.1016\/j.yrtph.2017.01.010_bib8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/toxsci\/kfm064","article-title":"Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach","volume":"97","author":"Gerberick","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2017.01.010_bib9","unstructured":"Harlan, 2014. http:\/\/old.harlan.com\/products_and_services\/research_models_and_services.hl."},{"year":"2009","series-title":"Recommended Performance Standards: Murine Local Lymph Node Assay","author":"ICCVAM","key":"10.1016\/j.yrtph.2017.01.010_bib10"},{"issue":"2","key":"10.1016\/j.yrtph.2017.01.010_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/15569520801904655","article-title":"The impact of vehicle on the relative potency of skin-sensitizing chemicals in the local lymph node assay","volume":"27","author":"Jowsey","year":"2008","journal-title":"Cutan. Ocul. Toxicol."},{"key":"10.1016\/j.yrtph.2017.01.010_bib12","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0095-4543(05)70183-4","article-title":"Occupational skin diseases","volume":"27","author":"Lushniak","year":"2000","journal-title":"Prim. Care"},{"year":"1992","series-title":"Skin Sensitization","author":"OECD","key":"10.1016\/j.yrtph.2017.01.010_bib13"},{"year":"2002","series-title":"Skin Sensitization: Local Lymph Node Assay","author":"OECD","key":"10.1016\/j.yrtph.2017.01.010_bib14"},{"year":"2012","series-title":"The Adverse Outcome Pathway for Skin Sensitisation Initiated by Covalent Binding to Proteins","author":"OECD","key":"10.1016\/j.yrtph.2017.01.010_bib15"},{"year":"2012","series-title":"The Adverse Outcome Pathway for Skin Sensitisation Initiated by Covalent Binding to Proteins","author":"OECD","key":"10.1016\/j.yrtph.2017.01.010_bib16"},{"year":"2015","series-title":"In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA)","author":"OECD","key":"10.1016\/j.yrtph.2017.01.010_bib17"},{"year":"2015","series-title":"In\u00a0Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Methods","author":"OECD","key":"10.1016\/j.yrtph.2017.01.010_bib18"},{"year":"2016","series-title":"In\u00a0Vitro Skin Sensitisation: Human Cell Line Activation Test (H-CLAT)","author":"OECD","key":"10.1016\/j.yrtph.2017.01.010_bib19"},{"year":"2016","series-title":"Guidance Document on the Reporting of Defined Approaches and Individual Information Sources to be Used within Integrated Approaches to Testing and Assessment (IATA) for Skin Sensitization","author":"OECD","key":"10.1016\/j.yrtph.2017.01.010_bib20"},{"key":"10.1016\/j.yrtph.2017.01.010_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.yrtph.2016.08.007","article-title":"Can currently available non-animal methods detect pre and pro-haptens relevant for skin sensitization?","volume":"82","author":"Patlewicz","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.yrtph.2017.01.010_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.14573\/altex.1411011","article-title":"Integrated testing strategies (ITS) for safety assessment","volume":"32","author":"Rovida","year":"2015","journal-title":"Altex"},{"issue":"2","key":"10.1016\/j.yrtph.2017.01.010_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.yrtph.2014.12.008","article-title":"Assessing skin sensitization hazard in mice and men using non-animal test methods","volume":"71","author":"Urbisch","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"5","key":"10.1016\/j.yrtph.2017.01.010_bib24","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1021\/acs.chemrestox.6b00055","article-title":"Assessment of pre- and pro-haptens using nonanimal test methods for skin sensitization","volume":"29","author":"Urbisch","year":"2016","journal-title":"Chem. Res. Toxicol."},{"year":"2008","series-title":"Marzulli and Maibach's Dermatotoxicology","author":"Zhai","key":"10.1016\/j.yrtph.2017.01.010_bib25"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230017300107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230017300107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T14:59:42Z","timestamp":1536073182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230017300107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":25,"alternative-id":["S0273230017300107"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2017.01.010","relation":{},"ISSN":["0273-2300"],"issn-type":[{"type":"print","value":"0273-2300"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of skin sensitization under REACH: A case report on vehicle choice in the LLNA and its crucial role preventing false positive results","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2017.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}